Intravenous thrombolytic therapy for acute ischemic stroke.

@article{Wechsler2011IntravenousTT,
  title={Intravenous thrombolytic therapy for acute ischemic stroke.},
  author={Lawrence R. Wechsler},
  journal={The New England journal of medicine},
  year={2011},
  volume={364 22},
  pages={
          2138-46
        }
}
  • L. Wechsler
  • Published 1 June 2011
  • Medicine
  • The New England journal of medicine
An 81-year-old man presents to the ER with an acute ischemic stroke; IV thrombolytic therapy is recommended. Administered as a therapeutic agent within 4.5 hours after stroke, tissue plasminogen activator has been shown to improve neurologic outcomes. 
Clinical characteristics and risk score for poor clinical outcome of acute ischemic stroke patients treated with intravenous thrombolysis therapy
TLDR
Clinical characteristics of stroke patients are investigated and predictors for poor clinical outcome in response to t‐PA treatment are determined.
Safety of Carotid Endarterectomy After Intravenous Thrombolysis for Acute Ischaemic Stroke: A Case-Controlled Multicentre Registry Study
Safety of carotid endarterectomy after intravenous thrombolysis for acute ischaemic stroke : a case-controlled multicentre registry study
Ischemic stroke: the first 24 hours.
Patients who have suffered a stroke are often left with a high incidence of physical and psychosocial impairments. Institutions must develop and implement clinical protocols and pathways to quickly
Mechanical thrombectomy for emergent large vessel occlusion: a critical appraisal of recent randomized controlled clinical trials
After numerous attempts to prove efficacy for endovascular treatment of ischemic stroke, a series of recent randomized controlled clinical trials (RCTs) established fast mechanical thrombectomy (MT)
Safety of urgent carotid endarterectomy following thrombolysis.
TLDR
The aggregate data from the 21 reported series suggest that CEA can be performed safely within the first 14 days after the onset of neurologic symptoms in patients receiving antecedent IVT, however, data regarding the safety of urgent CEA within 48 to 72 hours of thrombolysis is conflicting.
Malignant Ischemic Infarction
TLDR
The most reliable predictors of a “malignant” course for a large hemispheric infarction are hypodensity in more than 50 % of the MCA territory as well as stroke volume >145 mL on diffusion-weighted imaging.
Better Characterization of Transient Ischemic Attack Might Improve the Benefit: Risk Profile of Thrombolysis
  • O. Jolobe
  • Medicine
    Journal of the American Geriatrics Society
  • 2012
TLDR
By excluding cerebral infarction, MRI might also mitigate the risk of inappropriate thrombolysis in individuals who present with TIA in the presence of cerebral amyloid angiopathy (CAA), given that CAA has its highest prevalence in that age group.
Acute Stroke Care and Thrombolytic Therapy Use in a Tertiary Care Center in Lebanon
TLDR
In this setting, rt-PA utilization was higher than expected and public education regarding stroke is needed to decrease time from symptoms onset to ED presentation and potentially improve outcomes further.
Very Early Carotid Endarterectomy After Intravenous Thrombolysis.
  • C. Azzini, M. Gentile, +5 authors I. Casetta
  • Medicine
    European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery
  • 2016
TLDR
This experience suggests that very early CEA after thrombolysis, aimed at removing the source of potential embolisation and restoring blood flow, may be safe and can lead to a favourable outcome.
Is there Still a Time Window in the Treatment of Acute Stroke?
TLDR
Defining a patient-based therapeutic window to replace strict time windows and therefore refining patient exclusion and inclusion criteria is possible through understanding pathophysiology of acute ischemic stroke in individual patients.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 92 REFERENCES
Guidelines for the Early Management of Adults With Ischemic Stroke
Purpose— Our goal is to provide an overview of the current evidence about components of the evaluation and treatment of adults with acute ischemic stroke. The intended audience is physicians and ot...
Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.
TLDR
Despite an increased frequency of early symptomatic intracranial hemorrhage, treatment with IA r-proUK within 6 hours of the onset of acute ischemic stroke caused by MCA occlusion significantly improved clinical outcome at 90 days.
Treatment of acute ischemic stroke.
TLDR
In June 1996, the Food and Drug Administration approved tissue plasminogen activator (t-PA) as a safe and effective treatment for stroke if it is given within three hours after the onset of symptoms of stroke.
Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)
TLDR
Intravenous thrombolysis in acute ischemic stroke is effective in improving some functional measures and neurologic outcome in a defined subgroup of stroke patients with moderate to severe neurologic deficit and without extended infarct signs on the initial CT scan, however, the identification of this subgroup is difficult.
Thrombolysis-Related Hemorrhagic Infarction: A Marker of Early Reperfusion, Reduced Infarct Size, and Improved Outcome in Patients With Proximal Middle Cerebral Artery Occlusion
TLDR
Thrombolysis-related HI (HI1-HI2) represents a marker of early successful recanalization, which leads to a reduced infarct size and improved clinical outcome in patients with acute stroke caused by proximal middle cerebral artery occlusion treated with rtPA.
Thrombolysis in patients older than 80 years with acute ischaemic stroke: Canadian Alteplase for Stroke Effectiveness Study
TLDR
In carefully selected elderly patients, the use of intravenous tPA was not found to be associated with an increased risk of symptomatic intracerebral haemorrhage and age-related differences were seen in the clinical characteristics and outcome in the elderly population.
Tissue plasminogen activator for acute ischemic stroke.
  • Koroshetz Wj
  • Medicine
    The New England journal of medicine
  • 1995
TLDR
Despite an increased incidence of symptomatic intracerebral hemorrhage, treatment with intravenous t-PA within three hours of the onset of ischemic stroke improved clinical outcome at three months.
Guidelines for management of ischaemic stroke and transient ischaemic attack 2008.
TLDR
The article covers referral and emergency management, Stroke Unit service, diagnostics, primary and secondary prevention, general stroke treatment, specific treatment including acute management, management of complications, and rehabilitation.
Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.
CONTEXT Tissue-type plasminogen activator (tPA) is the only therapy for acute ischemic stroke approved by the Food and Drug Administration. OBJECTIVE To assess the safety profile and to document
Ultrasound‐Enhanced Thrombolysis for Acute Ischemic Stroke: Phase I. Findings of the CLOTBUST Trial
TLDR
Continuous TCD insonation for up to 2 hours at maximum intensities allowed by current bio‐safety guidelines is safe and Dramatic recovery and complete recanalization shortly after TPA bolus are feasible goals for thrombolysis given with TCD monitoring.
...
1
2
3
4
5
...